BNP Paribas Funds Health Care Innovators Classic Capitalisation

Fond informasjon

ISIN
LU0823416762
Valuta
EUR
SFDR
Kategori
Aksjefond
Risiko
6
Startdato
2013-05-17
NAV
1668.41

Avkastning

1 dag
0.09%
1 uke
-1.56%
YTD
25.54%
1 måned
0.70%
3 måneder
12.23%
6 måneder
12.09%
12 måneder
25.54%
3 år
9.28%
5 år
6.50%
10 år
12.60%

Kostnader

Forvaltningshonorar
1.50%
Ongoing kostnad
1.96%
Transaksjonskostnad
0.22%
Innslagskostnad
3.00%

Investeringsstrategi

The investment objective of the fund is to increase the value of its assets over the medium term by investing in healthcare innovative companies.

Forvaltere

Jon Stephenson
Jon manages the team’s investments in the health care sector and is the lead portfolio manager on its Health Care Innovators strategy . Earlier in his career, Jon spent five years with Pioneer Investments as a portfolio manager, working on a range of growth strategies. Previous to that, Jon was Director of Research with Summer Street Research Partners. Early in his career, he worked with State Street Research & Management as a research analyst covering the health care sector. He earned his BA from the Bucknell University. A member of the CFA Institute, Jon is a CFA charterholder
Christian Fay
Chris Fay joined BNP Paribas Asset Management in 2013 from Pioneer Investment Management in Boston where he was a portfolio manager and analyst covering the global health care sector. Prior to that, he was an institutional healthcare consultant with Leerink Swann & Co. and Kendall Strategies Inc. Earlier in his career he was employed by The Massachusetts Department of Public Health as the Chief of Administration and Finance. Chris earned his B.A. from the George Washington University. He received a M.S. in Biology from Loyola University of Chicago, a Masters in Public Health from Boston University and an M.B.A. from the Carroll School of Management, Boston College.

BNP Paribas Funds Health Care Innovators Classic Capitalisation

The investment objective of the fund is to increase the value of its assets over the medium term by investing in healthcare innovative companies.

Fondet praktiserer svingprising, for mer informasjon om hvordan fondet anvender svingprising, se fondets prospekt. Svingfaktoren evalueres kvartalsvis og ved ekstraordinære hendelser i markedene.